Nov 15, 2023
GLP-1 drugs are gaining popularity as an innovative solution to weight loss. With almost 43% of the US population being obese, this presents a strategic opportunity for the healthcare industry. Only 20% of Semaglutide users experience side effects, and the significant advertising spending by Rx manufacturers is driving demand for this new class of weight loss drugs.
In episode 48 of Kantar's Retail Sound Bites, hosts Barry Thomas, senior retail thought leader, and Rachel Dalton, head of retail insights, discuss GLP-1 medications and their influence on the retail landscape with nurse practitioners Leslie Thomas and Cathy Watkins lead the Signature Image Medical Spa in Atlanta, GA.
Have a topic you’d like us to cover? Contact us at Kantar’s Retail Sound Bites Podcast.
OpenAI’s new GPTs now let uses create custom versions of ChatGPT www.openai.com
Viral streamer partners with Kellogg’s veteran to launch BFY snack company https://www.usatoday.com/story/money/food/2023/11/13/twitch-streamer-pokimane-launches-myna-snacks/71136108007/
Pizza Hut’s ‘Your Mood, Your Pizza’ campaign uses AI to suggest items www.dominos.com